Alongside expression of RTN4A, comprising 76% total astrocytes in the injured cohort and 21% in control, we observed robust expression of GAP43, CD44 and KLF6, with both the percent of nuclei expressing these genes and the overall level of expression significantly increased after stroke (Fig. 2a). The gene discussed is RTN4; the disease is Stroke.